Global increase and geographic convergence in antibiotic consumption between 2000 and 2015 | PNAS
The MCR-9 gene, which causes antimicrobial resistance, was recently found in Georgia
A gene that causes bacteria to be resistant to one of the world’s most important antibiotics, colistin, has been detected in sewer water in Georgia. The presence of the MCR-9 gene is a major concern for public health because it causes antimicrobial resistance, a problem that the World Health Organization has declared “one of the top 10 global public health threats facing humanity.”
Researchers from the University of Georgia’s Center for Food Safety (CFS) collected sewage water from an urban setting in Georgia to test for the MCR gene in naturally present bacteria. Led by College of Agricultural and Environmental Sciences assistant professor Issmat Kassem, whose research focuses on MCR’s presence around the world, the team was surprised at how quickly they detected MCR — they found evidence of the gene in the first sample they took.
Kassem said that demonstrates that the gene is becoming established in the U.S.
The bacteria where the gene was found, Morganella morganii, added further concern for Kassem. This marked the first time that MCR was found in M. morganii, which is problematic because it is a bacteria not often tested by researchers. This means that the problem could be considerably more widespread than initially thought.
The spread of MCR in agriculture, imports, travel
It was previously believed that agriculture was a driving factor in the spread of MCR. Nations such as China and India use the colistin antibiotic in livestock. Colistin is considered a “last resort” antibiotic because it can kill infections that other antibiotics cannot. Its frequent use means that some bacteria are becoming resistant to it. This means that if people or animals contract a strain of colistin-resistant bacteria, there are potentially no medications that can treat their infection. They face extreme, invasive health measures and possible death.
Colistin is banned in the U.S. for use in food animals and it was previously thought that this measure would help slow the spread of antimicrobial resistance to colistin in the country. However, MCR can be spread through global travel and the import of foods from other countries. Results of the CFS study prove that the U.S. is no less susceptible to the threat than other nations around the world.
Further complicating the issue is the way that the gene is spread. It transmits in plasmids, which are strands of DNA found inside cells that can replicate on their own, independent of the cell. A plasmid with antimicrobial resistance found in one type of bacteria can transmit to other types of bacteria. This means that bacteria like E. coli and Salmonella that commonly cause outbreaks in humans can potentially carry MCR, turning them from treatable illnesses to potentially deadly infections.
How worried should we be about the MCR-9 gene?
Kassem said that taken all together, the global threat of antimicrobial resistance, the presence of MCR in Georgia, that it was found inside a bacterium that is often overlooked, and that it occurred even without the use of colistin in U.S. agriculture is a serious problem that requires immediate action on the part of many industries including research, healthcare and government to work together toward a solution.
“If we don’t tackle it right now, we are jeopardizing human and animal medicine as we know it and that can have huge repercussions on health and the economy,” Kassem said. “It’s a dangerous problem that requires attention from multiple sectors for us to be able to tackle it properly.”
Because of this urgency, findings from the research were printed in short format manuscript out now in the Journal of Global Antimicrobial Resistance.
Original Article: Gene discovered in Georgia water a possible global threat
More from: University of Georgia
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Antimicrobial resistance
- A vaccine to combat antibiotic resistance
A team of researchers at Michigan State University have outlined an approach to combating a prevalent public health issue: the development of treatment-res | Technology ...
- Cats And Dogs Can Spread Antibiotic Resistant Superbugs To Owners
Transfer of bacteria between sick pets and their humans may be contributing to antibiotic resistance, according to new research.
- Dr. James Gill's insights on combating the global crisis of antimicrobial resistance
Dr. James Gill, a Clinical Lecturer at the University of Warwick and a practicing GP, will attend a pivotal event hosted at the House of Lords on Monday (April 29) focused on combating the global ...
- Experts develop way to harness CRISPR technology to deal with antimicrobial resistance
Antimicrobial resistance (AMR) is continuing to increase globally, with rates of AMR in most pathogens increasing and threatening a future in which every day medical procedures may no longer be ...
- CRISPR is promising to tackle antimicrobial resistance, but bacteria can fight back
In his presentation "How to use CRISPR-Cas to combat AMR" at the ESCMID Global Congress, Assistant Prof. Ibrahim Bitar, Department of Microbiology, Faculty of Medicine and University Hospital in Plzen ...
Go deeper with Google Headlines on:
Antimicrobial resistance
[google_news title=”” keyword=”antimicrobial resistance” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
MCR-9 gene
- FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
- Gene Chamberlain
© 2024 ABG-SI LLC. SPORTS ILLUSTRATED IS A REGISTERED TRADEMARK OF ABG-SI LLC. - All Rights Reserved. The content on this site is for entertainment and educational ...
- Gene Therapy News
Apr. 22, 2024 — Clarifying the cause of a skin disease led to the discovery of a new disease-causing gene, a new category of diseases, and new perspectives for both counseling and therapy.
- Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research, develop and commercialize gene editing therapies for multiple diseases, the companies said on Thursday. Mammoth's CRISPR ...
- MCR and BLT Complete $632 Million Refinancing of 53-Hotel Portfolio
MCR, and Building and Land Technology (BLT), a premier real estate firm that has developed more than 25 million square feet of real estate across commercial and residential properties, have closed ...
Go deeper with Google Headlines on:
MCR-9 gene
[google_news title=”” keyword=”MCR-9 gene” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]